Palmer Raymond D
Full Spectrum Biologics South Perth Western Australia Australia.
School of Aging, Science of Aging South Perth Western Australia Australia.
Aging Med (Milton). 2022 Dec 12;5(4):281-286. doi: 10.1002/agm2.12231. eCollection 2022 Dec.
As longevity companies emerge with new products and the fields of anti-aging research develop new cutting-edge therapies, three distinct classes of longevity methodologies emerge. This discussion finds that there are three clear classes (Tiers) of longevity systems that are currently under development, and all three will be paramount to achieve biological escape velocity (where tissues can be repaired faster than aging can damage them). These classes are referred to as Tier 1, Tier 2, and Tier 3 treatments and are described in detail below. These three Tiers are required for easy identification for pharmaceutical companies and research companies to determine the type of therapy they may choose to deliver being noninvasive, invasive, time consuming, or simple end user products. Specific targets and goals need to be defined clearly from an early perspective in the development of these technologies for future precision medicines. This allows consumers of future anti-aging technologies to consider which Tier a particular therapy may be, delivering a more informed choice.
随着长寿公司推出新产品,抗衰老研究领域开发出新的前沿疗法,出现了三类不同的长寿方法。本次讨论发现,目前正在开发的长寿系统有三个明确的类别(层级),这三个类别对于实现生物逃逸速度(即组织修复速度快于衰老破坏速度)都至关重要。这些类别被称为一级、二级和三级治疗,具体描述如下。这三个层级便于制药公司和研究公司识别,以确定他们可能选择提供的治疗类型,是无创的、有创的、耗时的还是简单的终端用户产品。在这些技术的早期开发阶段,就需要明确界定具体的目标,以便未来开发精准药物。这使未来抗衰老技术的消费者能够考虑特定疗法可能属于哪个层级,从而做出更明智的选择。